Lockheed Martin Q2 Results Surge on Record Backlog and Missile Ramp

What happened

Lockheed Martin reported Q2 2026 sales of $20.1B, up 11% YoY, with net earnings of $1.8B ($7.94 EPS), beating expectations and reversing the negative free cash flow seen in Q1. Cash from operations hit $3.2B and free cash flow reached $2.9B, while the backlog soared to a record $230B, driven by the multi-year THAAD interceptor contract. This validates the missile-defense scaling thesis and suggests funded demand is converting into contractual visibility. However, Aeronautics and RMS segments still face headwinds, and the backlog includes long-dated orders that may not convert to cash quickly. The updated 2026 outlook implies confidence, but supply-chain risks and working-capital demands remain active.

Implication

Lockheed's backlog surge and FCF recovery confirm the missile ramp thesis, but the inflated backlog includes long-term orders and cash conversion consistency is key. A disciplined entry near $460 offers better risk/reward; monitor whether backlog growth translates into sustained FCF above $6.5B over the next two quarters.

Thesis delta

The massive jump in backlog from $186.4B to $230B, driven by the THAAD contract, validates the bull scenario faster than anticipated and reduces the risk of backlog decline. However, the backlog includes long-dated orders, so near-term conversion to cash must still be proven. Q2 FCF recovery is encouraging, but consistency is needed to confirm the ramp is generating cash, not just headlines.